Lipella Pharmaceuticals Inc. Operating Lease Right-of-Use Assets
Lipella Pharmaceuticals Inc. (LIPO) had Operating Lease Right-of-Use Assets of $262.82 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-14
- 2025-09-30: Operating Lease, Right-of-Use Asset $262.82K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $274.54K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $23.57K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $46.75K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $262.82K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $274.54K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $23.57K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $46.75K 10-Q · filed 2025-11-14 |
| 2024-09-30 | $69.56K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $91.98K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $114.04K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $135.14K 10-K · filed 2025-03-28 |
| 2023-09-30 | $156.41K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $122.55K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $136.79K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $150.82K 10-K · filed 2024-02-27 |
| 2021-12-31 | $204.80K 10-K · filed 2023-03-31 |